Making a new technology work: The standardization and regulation of microarrays

Yale Journal of Biology and Medicine

Volumn 80, Issue 4, 2007, Pages 165-178

  Rogers, Susan ^a   Cambrosio, Alberto ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; GENE EXPRESSION; GENOMICS; MICROARRAY ANALYSIS; REVIEW; DNA MICROARRAY; GENE EXPRESSION PROFILING; GOVERNMENT REGULATION; HEALTH CARE QUALITY; INTERNATIONAL COOPERATION; STANDARD;

BIOTECHNOLOGY; GENE EXPRESSION PROFILING; GOVERNMENT REGULATION; INTERNATIONALITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUALITY ASSURANCE, HEALTH CARE; REFERENCE STANDARDS;

EID: 44849117559     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Baird D. Thing knowledge. A philosophy of scientific instruments. Berkeley: University of California Press; 2004.
2. Collins HM. Changing order: replication and induction in scientific practice. 2nd ed. Chicago: University of Chicago Press; 1992.
3. Rader K. Making mice: Standardizing animals for American biomedical research, 1900-1955. Princeton: Princeton University Press; 2004.
4. Löwy I, Gaudillière JP. Disciplining cancer: Mice and the practice of genetic purity. In: Gaudillière JP and Löwy I, editors. The Invisible industrialist: manufacturers and the construction of scientific knowledge. London: Macmillan; 1998. p. 209-49.
5. O'Connell J. Metrology: The creation of universality by the circulation of particulars. Social Studies of Science. 1993;23:129-73.
6. Mallard A. Compare, standardize and settle agreement. On some usual metrological problems. Social Studies of Science. 1998; 28:571-601.
7. Schaffer S. Late Victorian metrology and its instrumentation: A manufactory of Ohms. In: Bud R, Cozzens SE, editors. Invisible connections: instruments, institutions, and science. Bellingham, Washington: SPIE Optical Engineering Press; 1992. p. 23-56.
8. Keating P, Cambrosio A. Interlaboratory life: regulating flow cytometry. In: Gaudillière JP, Löwy I, editors. The invisible industrialist: manufacturers and the construction of scientific knowledge. London: Macmillan; 1998. p. 250-95.
9. Canguilhem G. The normal and the pathological. New York: Zone Books; 1989.
10. Timmermans S, Berg M. The gold standard: the challenge of evidence-based medicine and standardization in health care. Philadelphia: Temple University Press; 2003.
11. Cambrosio A, Keating P, Schlich T, Weisz G. Regulatory objectivity and the generation and management of evidence in medicine. Soc Sci Med. 2006;63:189-99.
12. Keating P, Cambrosio A. Cancer clinical trials: The emergence and development of a new style of practice. Bull Hist Med. 2007;81:197-223
13. Cambrosio A, Keating P, Mogoutov A. Mapping collaborative work and innovation in biomedicine: A computer-assisted analysis of antibody reagent workshops. Social Studies of Science. 2004;34:325-64.
14. Bourret P, Mogoutov A, Julian-Reynier C, Cambrosio, A. A new clinical collective for French cancer genetics: A heterogeneous mapping analysis. Science, Technology, & Human Values. 2006;31:431-64.
15. Harris NL, Horning SJ. Burkitt's lymphoma: The message from microarrays. N Engl J Med. 2006;354:2495-8.
16. Quackenbush J. Microarray analysis and tumour classification. N Engl J Med. 2006;354:2463-72.
17. Perkel JM. Medicine gets personal. With new regulations and new diagnostics, pharmacogenetics comes to the clinic. The Scientist. 2005;19(8):34.
18. Simon R, Wang SJ. Use of genomic signatures in therapeutics development in oncology and other diseases. Pharmacogenomics J. 2006;6:166-173.
19. Keating P, Cambrosio A. Signs, markers, profiles, and signatures: Clinical hematology meets the new genetics (1980-2000). New Genetics and Society. 2004;2:15-45.
20. Mogoutov A, Cambrosio A, Keating P, Mustar P. Biomedical innovation at the laboratory, clinical and commercial interface: mapping research projects, publications and patents in the field of microarrays. Paper presented at the 6th Biennial International Triple Helix Conference on University-Industry Government-Links; 2007 May 16-18; Singapore.
21. Frost and Sullivan, U.S. DNA Microarray Markets (Dec. 29, 2005).
22. Frost and Sullivan, Strategic Analysis of World DNA Microarray Markets (Mar. 1, 2004).
23. Datamonitor Company Profiles. Document Code DCC06282-9FEA-4BD4-A49B- DCB7E4C2E4F4 (Affymetrix/April 2007) and A8DD7B13-69B1-4126-A04C-71F7920B1876 (Illumina/May 2007).
24. Fodor SP, Read JL, et al. Light-directed, spatially addressable parallel chemical synthesis. Science.1991;251(4995):767.
25. Microarray analysis resource: Microarray basics. Microarrays vs. macroarrays [Ambion internet page; last accessed 2007 Nov 1]. Available from: http://www.ambion.com/techlib/resources/microarray/basics2.html.
26. Lopez MF, Pluskal MG. Protein micro-and macroarrays: digitizing the proteome. J Chromatography A. 2003;787(1):19-27.
27. Lipshutz RJ, Morris D, et al. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques. 1995;19(3):442-7.
28. Gerhold D, Rushmore T, Caskey CT. DNA chips: promising toys have become powerful tools. Trends Biochem Sci. 1999;24:168-73.
29. Schena M, Shalon D, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270(5235):467-70.
30. Michael M. Futures of the present: From performativity to prehension. In: Brown N, Rappert B, Webster A, editors. Contested futures: A sociology of prospective techno-science. Aldershot: Ashgate. 2000. p. 21-42.
31. Lesko LJ, Woodcock J. Pharmacogenomic-guided drug development: regulatory perspective. Pharmacogenomics J. 2002;2:20-4.
32. Nowak R. Entering the postgenome era. Science. 1995;270:368-71.
33. DeRisi J, et al. Use of cDNA Microarray to analyse gene expression patterns in human cancer. Nat Genet. 1996;14:457-60.
34. Star R, Rasooly RS. Searching for array standards in Rockville. Nat Biotechnol. 2001;19:418-19.
35. Bammler T, Beyer RP, et al. Standardizing global gene expression analysis between laboratories and across platforms. Nature Methods. 2005;2:477
36. Brazma A. On the importance of standardization in the life sciences [editorial]. Bioinformatics. 2001;17(2):113-14.
37. Botstein D. Editorial. Mol Biol Cell. 1998;9:7.
38. Afshari CA. Perspective: microarray technology, seeing more than spots. Endocrinology. 2002; 143(6):1983-9.
39. Knight J. Minimum standards set out for gene-expression data. Nature. 2002;415:946.
40. Cambrosio A, Keating, P. Of lymphocytes and pixels: The techno-visual production of cell populations. Studies in History and Philosophy of Biological and Biomedical Sciences. 2000;31:233-70.
41. Simon R. Dr. Richard Simon outlines Microarray Myths and Truths. In: Division of Cancer Treatment and Diagnosis, Program Accomplishments (http://dctd.cancer.gov/includefiles/ DCTD.pdf). National Institutes of Health; 2006. p. 20.
42. Bijker W, Law J, editors. Shaping technology /building society. Studies in sociotechnical change. Cambridge: MIT Press; 1994.
43. Cambrosio A, Keating P, Mogoutov A. Mapping Collaborative Work and Innovation in Biomedicine: A Computer-Assisted Analysis of Antibody Reagent Workshops. Social Studies of Science. 2004;34:325-64.
44. McMeekin A, Harvey M. The Formation of Bioinformatic Knowledge Markets: An 'Economies of Knowledge' Approach. Revue d'Économie Industrielle. 2002;101:47-64.
45. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum Information About a Microarray Experiment (MIAME). Toward Standards for Microarray Data. Nat Genet. 2001;29:365-71.
46. Davenport RJ. Data standards on the horizon. Science. 2001;292(5516):414-15.
47. Brazma A, Robinson A, et al. One-stop shop for microarray: Is a universal, public DNA-microarray database a realistic goal? Nature. 2000;403:699-700.
48. Ball CA, Sherlock G, et al. A guide to microarray experiments-an open letter to the scientific journals. Lancet. 2002;360(9338):1019.
49. Microarray standards at last [Editorial]. Nature. 2002;419:323.
50. Shields R. MIAME, we have a problem [Editorial]. Trends Genet. 2006;22:65-66.
51. Taylor CF, Hermjakob H, Julian RK Jr, Garavelli JS, Aebersold R, Apweiler R. The work of the Human Proteome Organisation's Proteomics Standards Initiative (HUPO PSI). OMICS. 2006;10(2):145-51.
52. Taylor CF, Paton NW, et al. The minimum information about a proteomics experiment. Nat Biotechnol. 2007;25(8):887-93.
53. Orchard S, Salwinski L, Kerrien S, Montecchi-Palazzi L, Oesterheld M, Stümpflen V, et al. The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol. 2007;25:894-8.
54. Jones AR, Miller M, Aebersold R, Apweiler R, Ball CA, Brazma A, et al. The Functional Genomics Experiment model (FuGE): an extensible framework for standards in functional genomics. Nat Biotechnol. 2007;25:1127-33.
55. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25:25-29.
56. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, et al. The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006;24:1151-61.
57. Barry A. Political machines. Governing a technological society. London: Athlone Press; 2001.
58. Jasanoff S, editor. States of knowledge. The co-production of science and social order. London: Routledge; 2004.
59. Funkhouser J. Reinventing pharma: The theranostic revolution. Current Drug Discovery. 2002;2:17-19.
60. Warner S. Diagnostics+therapy=theranostics. The Scientist. 2004;18(16):38-9.
61. Petrone J. SNP chip prices appear to have plateaued, but some predict decrease in coming years. BioArray News [Internet]. 2007;7(38). Available from: http://www.bioarraynews.com/issues/7_38/features/142501-1.html.
62. Curtin C. Get ready for microarray diagnostics. Genome Technology [Internet]. September 2007. Available from: http://www.genome-technology.com/ issues/2_7/cover-story/141883-1.html.
63. Jarvis N, Centola M. Gene-espression profiling: Time for clinical application? Lancet. 2005;365:199-200.
64. Febbo PG, Kantoff PW. Noise and bias in microarray analysis of tumor specimens. Am J Clin Oncol. 2006;24:3719-21.
65. Krislov S. How nations choose product standards and standards change nations. Pittsburgh: University of Pittsburgh Press; 1997.